Immuno-Biological Laboratories Co., Ltd. 4570.T Stock
Immuno-Biological Laboratories Co., Ltd. Price Chart
Immuno-Biological Laboratories Co., Ltd. 4570.T Financial and Trading Overview
Contents
| Immuno-Biological Laboratories Co., Ltd. stock price | 484 JPY |
| Previous Close | 362 JPY |
| Open | 365 JPY |
| Bid | 366 JPY x 0 |
| Ask | 369 JPY x 0 |
| Day's Range | 362 - 368 JPY |
| 52 Week Range | 295 - 530 JPY |
| Volume | 29.4K JPY |
| Avg. Volume | 98.6K JPY |
| Market Cap | 3.43B JPY |
| Beta (5Y Monthly) | 0.391187 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -20.67 JPY |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | March 27, 2013 |
| 1y Target Est | N/A |
4570.T Valuation Measures
| Enterprise Value | 3.04B JPY |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 4.316566 |
| Price/Book (mrq) | 3.1793754 |
| Enterprise Value/Revenue | 3.826 |
| Enterprise Value/EBITDA | N/A |
Trading Information
Immuno-Biological Laboratories Co., Ltd. Stock Price History
| Beta (5Y Monthly) | 0.391187 |
| 52-Week Change | 17.91% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 530 JPY |
| 52 Week Low | 295 JPY |
| 50-Day Moving Average | 381.98 JPY |
| 200-Day Moving Average | 370.65 JPY |
4570.T Share Statistics
| Avg. Volume (3 month) | 98.6K JPY |
| Avg. Daily Volume (10-Days) | 39.55K JPY |
| Shares Outstanding | 9.31M |
| Float | 7.15M |
| Short Ratio | N/A |
| % Held by Insiders | 19.32% |
| % Held by Institutions | 3.13% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 10:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2023 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | March 31, 2024 |
Profitability
| Profit Margin | -36.39% |
| Operating Margin (ttm) | 6.54% |
| Gross Margin | 66.24% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | 2.07% |
| Return on Equity (ttm) | -23.62% |
Income Statement
| Revenue (ttm) | 794M JPY |
| Revenue Per Share (ttm) | 85.25 JPY |
| Quarterly Revenue Growth (yoy) | 20.59% |
| Gross Profit (ttm) | 527M JPY |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -289000000 JPY |
| Diluted EPS (ttm) | -9.87 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 614M JPY |
| Total Cash Per Share (mrq) | 65.93 JPY |
| Total Debt (mrq) | 234M JPY |
| Total Debt/Equity (mrq) | 21.71 JPY |
| Current Ratio (mrq) | 4.623 |
| Book Value Per Share (mrq) | 115.746 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 26M JPY |
| Levered Free Cash Flow (ttm) | 119.88M JPY |
Profile of Immuno-Biological Laboratories Co., Ltd.
| Country | Japan |
| State | N/A |
| City | Fujioka |
| Address | Fujioka Laboratory |
| ZIP | 375-0005 |
| Phone | 81 2 7422 2889 |
| Website | https://www.ibl-japan.co.jp |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Immuno-Biological Laboratories Co., Ltd. researches, develops, manufactures, and supplies various immunological research reagents worldwide. It offers a range of antibodies and ELISA kits that are used for research and development in the fields of cancers and Alzheimer's disease, as well as lifestyle diseases, such as diabetes. The company also provides contract services to pharmaceutical firms and manufacturers of diagnostic products; and supplies antibodies for in-vitro diagnostic products, as well as licenses antibody drugs. In addition, it offers LipoTEST, a support testing services for animal medical care; LipoSEARCH lipid profiling and analyzing services; customized biomarker testing services for lifestyle related diseases; and other services, which include drug development and research support services. Further, the company develops Neosilk-Human Collagen I from transgenic silkworms for various cosmetic products; and proteins from transgenic silkworms for use in various drugs. Its antibodies serve pharmaceutical firms, universities, and laboratories in hospitals, and testing centers. Immuno-Biological Laboratories Co., Ltd. was incorporated in 1982 and is headquartered in Fujioka, Japan.
Q&A For Immuno-Biological Laboratories Co., Ltd. Stock
What is a current 4570.T stock price?
Immuno-Biological Laboratories Co., Ltd. 4570.T stock price today per share is 484 JPY.
How to purchase Immuno-Biological Laboratories Co., Ltd. stock?
You can buy 4570.T shares on the Tokyo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Immuno-Biological Laboratories Co., Ltd.?
The stock symbol or ticker of Immuno-Biological Laboratories Co., Ltd. is 4570.T.
Which industry does the Immuno-Biological Laboratories Co., Ltd. company belong to?
The Immuno-Biological Laboratories Co., Ltd. industry is Biotechnology.
How many shares does Immuno-Biological Laboratories Co., Ltd. have in circulation?
The max supply of Immuno-Biological Laboratories Co., Ltd. shares is 9.31M.
What is Immuno-Biological Laboratories Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Immuno-Biological Laboratories Co., Ltd. PE Ratio is now.
What was Immuno-Biological Laboratories Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Immuno-Biological Laboratories Co., Ltd. EPS is -20.67 JPY over the trailing 12 months.
Which sector does the Immuno-Biological Laboratories Co., Ltd. company belong to?
The Immuno-Biological Laboratories Co., Ltd. sector is Healthcare.